Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:46 pm Unchanged | 2026-03-13 | 13G | ANI Pharmaceuticals, Inc. ANIP | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-11-13 4:28 pm Sale | 2025-09-30 | 13G | ANI Pharmaceuticals, Inc. ANIP | INTEGRATED CORE STRATEGIES (US) LLC | 65,245 0.300% | -1,051,415 (-94.16%) | Filing History |
| 2025-10-17 6:05 pm Purchase | 2025-09-30 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 2,517,424 11.300% | 2,517,424 (New Position) | Filing History |
| 2025-08-22 08:00 am Sale | 2025-08-21 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 1,034,570 4.800% | -150,000 (-12.66%) | Filing History |
| 2025-06-04 4:00 pm Purchase | 2025-05-30 | 13G | ANI Pharmaceuticals, Inc. ANIP | INTEGRATED CORE STRATEGIES (US) LLC | 1,116,660 5.200% | 1,116,660 (New Position) | Filing History |
| 2025-04-10 4:00 pm Sale | 2025-03-31 | 13G | ANI Pharmaceuticals, Inc. ANIP | MILLENNIUM MANAGEMENT LLC | 818,341 3.800% | -272,662 (-24.99%) | Filing History |
| 2025-03-13 8:50 pm Purchase | 2025-03-11 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 1,184,570 5.400% | 1,184,570 (New Position) | Filing History |
| 2025-01-21 4:04 pm Purchase | 2025-01-14 | 13G | ANI Pharmaceuticals, Inc. ANIP | MILLENNIUM MANAGEMENT LLC | 1,091,003 5.200% | 1,091,003 (New Position) | Filing History |
| 2024-11-13 4:30 pm Unchanged | 2024-11-13 | 13G | ANI Pharmaceuticals, Inc. ANIP | Rubric Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-14 07:30 am Unchanged | 2024-03-14 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 4:58 pm Unchanged | 2024-02-13 | 13G | ANI Pharmaceuticals, Inc. ANIP | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-12 06:06 am Unchanged | 2024-02-12 | 13G | ANI Pharmaceuticals, Inc. ANIP | Rubric Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-23 4:13 pm Unchanged | 2024-01-23 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-17 07:45 am Unchanged | 2024-01-17 | 13D | ANI Pharmaceuticals, Inc. ANIP | Esjay LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-18 5:18 pm Unchanged | 2023-12-18 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-05 4:30 pm Unchanged | 2023-12-05 | 13D | ANI Pharmaceuticals, Inc. ANIP | Esjay LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-08-17 6:22 pm Unchanged | 2023-08-17 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-26 08:52 am Unchanged | 2023-01-26 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Unchanged | 2023-01-20 | 13G | ANI Pharmaceuticals, Inc. ANIP | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-12-12 4:00 pm Unchanged | 2022-12-12 | 13D | ANI Pharmaceuticals, Inc. ANIP | Meridian Venture Partners II GP L.P. | 0 0.000% | 0 (Unchanged) | Filing |